Edgewise Therapeutics

Developer of therapeutics for skeletal and cardiac muscle diseases

placeBoulder, Colorado, United States calendar_todayFounded 2017 groups33 employees language edgewisetx.com

Registered entities

Social engagement

Social engagement: 18.4K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Novo Holdings, USVP, Viking Global Investors.

Investor typeCountShare
Venture capital429%
Private equity214%
Bank & private debt17%
Other / undisclosed750%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

2 Feb 2026 · Director, Information Security · Boulder

Based on job postings tracked across public sources.

Recent activity

2 Jul 2026
Event
International Congress on Neuromuscular Diseases - ICNMD
24 Jun 2026
Event
12th Congress of the European Academy of Neurology (EAN)
23 Jun 2026
Event
BIO International Convention 2026
Coming soon